共 50 条
- [21] Differing effects of methylenetetrahydrofolate reductase single nucleotide polymorphisms on methotrexate efficacy and toxicity in rheumatoid arthritis [J]. PHARMACOGENETICS, 2002, 12 (03): : 181 - 182
- [23] Association of Fcγ receptor IIIA polymorphism with rheumatoid arthritis:: comment on the article by Morgan et al [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (02): : 556 - 557
- [25] Effect of golimumab combined with methotrexate on radiographic progression in rheumatoid arthritis: comment on the article by Emery et al Reply [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (04): : 1298 - 1299
- [26] Monitoring guidelines for methotrexate-treated rheumatoid arthritis patients: comment on the article by Yazici et al - Reply [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (08): : 2710 - 2711
- [28] Effect of folic acid supplementation on the efficacy of methotrexate treatment in rheumatoid arthritis: comment on the article by Khanna et al [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1708 - 1709
- [29] Do infliximab and methotrexate act synergistically in the treatment of rheumatoid arthritis? Comment on the article by Maini et al - Reply [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (08): : 1779 - 1781
- [30] Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (10): : 3095 - 3103